000 | 02551cam a22003734a 4500 | ||
---|---|---|---|
003 | BUC | ||
005 | 20220404025024.0 | ||
008 | 200119s2010 flua g b i 001 0 eng | ||
010 | _a2009032763 | ||
020 | _a9781420084221 (hardcover : alk. paper) | ||
040 |
_aBADR UNIVERSITY IN CAIRO _cBADR UNIVERSITY IN CAIRO _beng _erda |
||
041 | 0 | _aeng | |
050 | 0 | 0 |
_aRS100 _b.P433 2010 |
082 | 0 | 0 |
_a338.476151 _222 _bPHA |
245 | 0 | 0 |
_aPharmacoeconomics : _bfrom theory to practice / _ceditor, Renee J.G. Arnold. |
260 |
_aBoca Raton, FL : _bTaylor & Francis, _cc2010. |
||
300 |
_axiv, 243 p. : _bill. ; _c25 cm. |
||
336 | _236 | ||
490 | 1 |
_aDrug discovery series ; _v13 |
|
504 | _aIncludes bibliographical references and index. | ||
505 | _aIntroduction to pharmacoeconomics / William F. McGhan -- Decision modeling techniques / Mark S. Roberts and Ken Smith -- Cost of illness / Renée J.G. Arnold -- Markov modeling in decision analysis / J. Robert Beck -- Retrospective database analysis / Renée J.G. Arnold and Sanjeev Balu -- What is cost-minimization analysis? / Alan Haycox -- Cost-effectiveness analysis / Kenneth J. Smith and Mark S. Roberts -- Budget impact analysis / Lieven Annemans -- Cost-utility analysis : a case study of a quadrivalent human Papillomavirus vaccine / Erik J. Dasbach, Ralph P. Insinga, and Elamin H. Elbasha -- Some problems/assumptions in pharmacoeconomic analysis / Stuart Birks -- Patient-reported outcome measures / Dianne Bryant, Gordon Guyatt, and Renée J.G. Arnold -- Sensitivity analysis / Maarten J. Postma -- Use of pharmacoeconomics in drug reimbursement in Australia, Canada, and the United Kingdom : what can we learn from international experience? / Michael Drummond and Corinna Sorenson -- Pharmacoeconomics in disease management : practical applications and persistent challenges / Ryung Suh and David Atkins -- Computer aided decision making from drug discovery to pharmacoeconomics / Sean Ekins and Renée J.G. Arnold -- Speculations on the future challenges and value of pharmacoeconomics / J. Jaime Caro, Denis .Getsios, and Rachael L. Fleurence | ||
650 | 0 |
_aDrugs _xCost effectiveness. |
|
650 | 0 |
_aPharmacy _xEconomic aspects. |
|
650 | 0 | _aDecision making. | |
650 | 1 | 2 | _aEconomics, Pharmaceutical. |
650 | 2 | 2 | _aCosts and Cost Analysis. |
650 | 2 | 2 | _aDecision Making. |
650 | 2 | 2 |
_aOutcome Assessment (Health Care) _xeconomics. |
700 | 1 | _aArnold, Renee J. G. | |
830 | 0 |
_aDrug discovery series ; _v13. |
|
902 | _aE.Anwer | ||
942 |
_2ddc _cBK |
||
999 |
_c2124 _d2124 |